EVYD Technology and A*STAR Launch $8M Joint AI Research Lab to Revolutionize Healthcare Solutions

EVYD Technology and Singapore’s Agency for Science, Technology and Research (A*STAR) have joined forces to establish a cutting-edge AI research lab focused on population health and digital health advancements. The collaboration aims to leverage the power of AI to enhance healthcare solutions and positively impact patient outcomes. 

A*STAR-EVYD Joint Lab will tackle various healthcare challenges, including developing a health domain data collection and wellness score to promote healthy habits, exploring a health concierge service utilizing large language models, implementing remote health monitoring for early detection of health issues, and streamlining diagnostic workflows to aid clinicians in data interpretation and diagnostic evaluation.

Related articles: First Made-in-Singapore Antibody-Drug Conjugate Approved to Enter Clinical Trials 

Singapore Takes the Lead for AI-Driven Healthcare Solutions

The partnership between EVYD Technology and A*STAR holds significant implications for the future of healthcare. By combining their expertise in AI research and healthcare, the collaboration is set to drive transformative innovations in the field. The development of a health concierge service and remote health monitoring capabilities can revolutionize patient care by optimizing treatment plans and improving healthcare provider capacity planning. 

Moreover, the implementation of AI-driven diagnostic workflows can enhance the accuracy and efficiency of data interpretation, ultimately benefiting patients and clinicians alike. This joint endeavor showcases the increasing importance of AI in healthcare and highlights Singapore’s commitment to becoming a leader in digital health solutions.

A*STAR’s Ongoing Pursuit of Groundbreaking Collaborations

The partnership between EVYD Technology and ASTAR is not the first of its kind involving the esteemed research agency. Earlier, ASTAR also teamed up with Johnson & Johnson Vision to create the Eye Health Digital Innovation Consortium, focusing on advancing eye health research. This consortium, a first in Asia-Pacific, aims to address the pressing eye health needs within the region and develop innovative solutions utilizing technologies like blockchain, AI, and data privacy preservation. 

Given the rising prevalence of vision impairment and myopia in the Asia-Pacific region, such collaborations are crucial in developing effective and accessible eye care solutions for the population. As A*STAR continues to forge alliances with leading industry players, Singapore is poised to make significant strides in digital health and AI-driven healthcare advancements, benefitting millions of people across the region.

Author

GeneOnline Team